Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386285527> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4386285527 endingPage "1236" @default.
- W4386285527 startingPage "1221" @default.
- W4386285527 abstract "ABSTRACT. We are reporting a novel series of thiosemicarbazone derivatives derived from isatin (1-6), structural determination, and investigation of the inhibitory properties against proliferative, carbonic anhydrase, and cholinesterase enzymes. The anti-proliferative effects of the compounds were measured by XTT assay against MCF-7 and MDA-MB-231 cancerous cell lines. Compound 3 showed significant cytotoxic effects on both MCF-7 and MDA-MB-231 cell lines, with IC50 values of 8.19 μM and 23.41 μM, respectively. In addition, the compounds (1-6) inhibited the hCA I and II, their Ki values 2.01 ± 0.35 – 21.55 ± 2.56 and 1.24 ± 0.33 – 25.03 ± 5.48 µM, respectively. AChE was also successfully inhibited by these compounds (1-6), with Ki values ranging from 40.37 ± 8.23 to 125.43 ± 24.93 µM. The best Ki values for 3, 6, and 4 for α-glycosidase were 564.35 ± 72.06, 594.38 ± 52.04, and 683.437 ± 66.58 µM, respectively. Binding affinities were determined to be -6.697 kcal/mol, -8.251 kcal/mol, -9.932 kcal/mol, and -4.946 kcal/mol for hCA I, hCA II, AChE, and α-glucosidase enzymes, respectively. These findings reveal that the formed compounds containing isatin moieties were crucial in the enzyme inhibition.
 
 KEY WORDS: Isatin, Thiosemicarbazone, Anti-proliferative activity, Enzyme inhibition, Molecular docking
 
 Bull. Chem. Soc. Ethiop. 2023, 37(5), 1221-1236. 
 DOI: https://dx.doi.org/10.4314/bcse.v37i5.14" @default.
- W4386285527 created "2023-08-31" @default.
- W4386285527 creator A5002765974 @default.
- W4386285527 creator A5002949310 @default.
- W4386285527 creator A5025294286 @default.
- W4386285527 creator A5029068779 @default.
- W4386285527 creator A5039206170 @default.
- W4386285527 creator A5039363889 @default.
- W4386285527 creator A5067282973 @default.
- W4386285527 creator A5067490959 @default.
- W4386285527 creator A5073914362 @default.
- W4386285527 creator A5075561764 @default.
- W4386285527 date "2023-07-03" @default.
- W4386285527 modified "2023-10-02" @default.
- W4386285527 title "Isatin/thiosemicarbohydrazone hybrids: Facile synthesis, and their evaluation as anti-proliferatıve agents and metabolıc enzyme inhibitors" @default.
- W4386285527 doi "https://doi.org/10.4314/bcse.v37i5.14" @default.
- W4386285527 hasPublicationYear "2023" @default.
- W4386285527 type Work @default.
- W4386285527 citedByCount "0" @default.
- W4386285527 crossrefType "journal-article" @default.
- W4386285527 hasAuthorship W4386285527A5002765974 @default.
- W4386285527 hasAuthorship W4386285527A5002949310 @default.
- W4386285527 hasAuthorship W4386285527A5025294286 @default.
- W4386285527 hasAuthorship W4386285527A5029068779 @default.
- W4386285527 hasAuthorship W4386285527A5039206170 @default.
- W4386285527 hasAuthorship W4386285527A5039363889 @default.
- W4386285527 hasAuthorship W4386285527A5067282973 @default.
- W4386285527 hasAuthorship W4386285527A5067490959 @default.
- W4386285527 hasAuthorship W4386285527A5073914362 @default.
- W4386285527 hasAuthorship W4386285527A5075561764 @default.
- W4386285527 hasBestOaLocation W43862855271 @default.
- W4386285527 hasConcept C178790620 @default.
- W4386285527 hasConcept C181199279 @default.
- W4386285527 hasConcept C185592680 @default.
- W4386285527 hasConcept C202751555 @default.
- W4386285527 hasConcept C2775914622 @default.
- W4386285527 hasConcept C2777256644 @default.
- W4386285527 hasConcept C2777752497 @default.
- W4386285527 hasConcept C55493867 @default.
- W4386285527 hasConcept C71240020 @default.
- W4386285527 hasConcept C83591994 @default.
- W4386285527 hasConceptScore W4386285527C178790620 @default.
- W4386285527 hasConceptScore W4386285527C181199279 @default.
- W4386285527 hasConceptScore W4386285527C185592680 @default.
- W4386285527 hasConceptScore W4386285527C202751555 @default.
- W4386285527 hasConceptScore W4386285527C2775914622 @default.
- W4386285527 hasConceptScore W4386285527C2777256644 @default.
- W4386285527 hasConceptScore W4386285527C2777752497 @default.
- W4386285527 hasConceptScore W4386285527C55493867 @default.
- W4386285527 hasConceptScore W4386285527C71240020 @default.
- W4386285527 hasConceptScore W4386285527C83591994 @default.
- W4386285527 hasIssue "5" @default.
- W4386285527 hasLocation W43862855271 @default.
- W4386285527 hasOpenAccess W4386285527 @default.
- W4386285527 hasPrimaryLocation W43862855271 @default.
- W4386285527 hasRelatedWork W2002540230 @default.
- W4386285527 hasRelatedWork W2291811291 @default.
- W4386285527 hasRelatedWork W2768142240 @default.
- W4386285527 hasRelatedWork W2890874837 @default.
- W4386285527 hasRelatedWork W3185100544 @default.
- W4386285527 hasRelatedWork W4224009098 @default.
- W4386285527 hasRelatedWork W4249578969 @default.
- W4386285527 hasRelatedWork W4379790522 @default.
- W4386285527 hasRelatedWork W4386285527 @default.
- W4386285527 hasRelatedWork W4386623875 @default.
- W4386285527 hasVolume "37" @default.
- W4386285527 isParatext "false" @default.
- W4386285527 isRetracted "false" @default.
- W4386285527 workType "article" @default.